🇺🇸 FDA
Patent

US 6545049

Dimer-selective RXR modulators and methods for their use

expired A61KA61K31/192A61K31/425

Quick answer

US patent 6545049 (Dimer-selective RXR modulators and methods for their use) held by Ligand Pharmaceuticals Incorporated expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Apr 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
36
CPC classes
A61K, A61K31/192, A61K31/425, A61K31/44, A61K31/4418